64B24-7.007: Responsibilities of Midwives During the Antepartum Period
PURPOSE AND EFFECT: To update the rule.
SUMMARY: The Department is moving HIV/AIDS screening to one of the tests within the complete history and physical examination provided for each patient.
SUMMARY OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 456.004(5), 467.005 FS.
LAW IMPLEMENTED: 467.015 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Pamela King, Council of Licensed Midwifery, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3250
THE FULL TEXT OF THE PROPOSED RULE IS:
64B24-7.007 Responsibilities of Midwives During the Antepartum Period.
(1) The licensed midwife shall:
(a) Require each patient to have a complete history and physical examination which includes:
1. Pap smear.
2. Serological screen for syphilis.
3. Gonorrhea and chlamydia screening.
4. Blood group including Rh factor and antibody screen.
5. Complete blood count (CBC).
6. Rubella titer.
7. Urinalysis with culture.
8. Sickle cell screening for at risk population.
9. Screen for hepatitis B surface antigen (HBsAG).
10. Screen for HIV/AIDS.
(b) Conduct the Healthy Start Prenatal Screen interview or assure that each patient has been previously screened.
(c) Provide counseling and offer screening related to the following:
1. Neural tube defects.
2. HIV/AIDS.
2.3. Group B Streptococcus.
3.4. CVS or genetic amniocentesis for women 35 years of age or older at the time of delivery.
4.5. Nutritional counseling.
5.6. Childbirth preparation.
6.7. Risk Factors.
7.8. Common discomforts of pregnancy.
8.9. Danger signs of pregnancy.
(d) Follow-up screening:
1. Hematocrit or hemoglobin levels at 28 and 36 weeks gestation.
2. Diabetic screening between 24 and 28 weeks gestation.
3. Antibody screen for Rh negative mothers, at 28 weeks gestation. Counsel and encourage RhoGAM prophylaxis. In those clients declining RhoGAM prophylaxis repeat antibody screen at 36 weeks.
(e) Require prenatal visits every four weeks until 28 weeks gestation, every two weeks from 28 to 36 weeks gestation and weekly from 36 weeks until delivery.
(2) through (7) No change.
Specific Authority 456.004(5), 467.005 FS. Law Implemented 467.015 FS. History–New 7-14-94, Formerly 61E8-7.007, 59DD-7.007, Amended 9-11-02, 7-21-03,_________.